메뉴 건너뛰기




Volumn 16, Issue 2, 2002, Pages 132-135

Delayed hypersensitivity to brimonidine tartrate 0.2% associated with high intraocular pressure

Author keywords

Allergy; Brimonidine; Intraocular pressure

Indexed keywords

ANTIHYPERTENSIVE AGENT; BRIMONIDINE; EYE DROPS; QUINOXALINE DERIVATIVE; BETAXOLOL; DORZOLAMIDE; LATANOPROST;

EID: 0035984871     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj/eye/6700053     Document Type: Article
Times cited : (15)

References (8)
  • 2
    • 0029774226 scopus 로고    scopus 로고
    • Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: A review of safety, efficacy, dose response, and dosing studies
    • (1996) Surv Ophthalmol , vol.41 , pp. S19-S26
    • Walters, T.R.1
  • 4
    • 0031793877 scopus 로고    scopus 로고
    • Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension
    • for the Brimonidine Study Group 2
    • (1998) Ophthalmology , vol.105 , pp. 1960-1967
    • LeBlanc, R.P.1
  • 7
    • 0029731441 scopus 로고    scopus 로고
    • A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure
    • Brimonidine Study Group III
    • (1996) Surv. Ophthalmol , vol.41 , pp. S39-S47
    • Serle, J.B.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.